Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.
Hidradenitis suppurativa patients without cardiometabolic disease are less likely to attend primary care.
Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.
Hidradenitis suppurativa (hidradenitis suppurativa) is linked to cardiometabolic disease (cardiometabolic disease), and guidelines recommend annual primary care visits.
This study examined predictors of primary care utilization among patients with hidradenitis suppurativa.
In this cross-sectional study, 307 patients with hidradenitis suppurativa were analyzed. χ 2 tests, one-way analysis of variance, and multivariable logistic regression assessed associations among barriers to care, primary care provider (primary care provider) adherence, hidradenitis suppurativa severity, and cardiometabolic disease presence.
without heart or metabolic disease, patients skip yearly primary care far more often
Mean age was 39.4 years; 26.4% had Hurley stage III disease.
Overall primary care provider adherence was 85.0% but lower in patients under 30 years (71.0%).
Cardiometabolic disease prevalence included hypertension (33.9%), type 2 diabetes (17.6%), and hypercholesterolemia (32.9%).
Hidradenitis suppurativa severity did not predict adherence, but Hurley stage III disease was associated with more primary care provider visits and independently predicted type 2 diabetes (AOR, 2.26; P = .02).
Primary care engagement is influenced more by cardiometabolic disease and insurance than hidradenitis suppurativa severity.
Coordinated dermatology-primary care strategies may enhance preventive care, especially for younger patients without cardiometabolic disease.